TOP TIERMARKET NEWSWIRE
SEC Form 4 history

Evommune, Inc. (EVMN) insider trades

Evommune, Inc. (EVMN) insider trading activity (SEC Form 4). Over the trailing 90 days, EVMN insiders filed 2 purchases totalling $146K and 0 sales totalling $0 — net BUYING of $146K. Most recent filing: Jul 10, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
2
$146K
Sells (90d)
0
$0
Net (90d)
+$146K
net buying
Most recent
Jul 10, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 10, 2026Carver KyleCFOP Purchase—$13.26$13Kfiling
Jul 8, 2026Kirsch Arthur SDirP Purchase—$13.30$133Kfiling
Jun 24, 2026Pena Luis C.Pres, CEOS Sale—$22.71$169Kfiling
Jun 24, 2026Patel Jeegar PravinkumarChief Scientific OfficerS SaleOE—$22.50$33Kfiling
Jun 24, 2026Drew Janice SuzannChief of Dev. OperationsS SaleOE—$22.63$453Kfiling
Jun 3, 2026Cohen David EDirS SaleOE—$20.33$123Kfiling
Jun 3, 2026Pena Luis C.Pres, CEOS Sale—$22.74$382Kfiling
Jun 3, 2026Patel Jeegar PravinkumarChief Scientific OfficerS SaleOE—$22.74$379Kfiling
Jun 1, 2026Carver KyleCFOS SaleOE—$22.84$415Kfiling
Jun 1, 2026Moss Gregory S.Chief Business, Legal OfficerS SaleOE—$22.83$325Kfiling